This month, Merck’s Mavenclad (cladribine) become available in the UK to treat highly active relapsing multiple sclerosis (MS). Mavenclad is the first high efficacy, infrequent dosing oral agent approved for...
28 September 2017
10 August 2017
With the fast development of IBM’s Watson and Google’s DeepMind, artificial intelligence (AI) is one of the key terms in 2017. GlobalData believes that AI will inevitably be used in...
31 July 2017
Amazon is headed towards a new venture in health technology. CNBC reported that the company has a healthcare team that is focused on virtual doctor visits and health apps.
3 July 2017
The ability to edit the human genome has been eagerly anticipated for many years. While the possibilities are exciting for many, there are serious ethical concerns that are already beginning...
25 June 2017
The current method of obtaining a diagnosis for cancer is by histopathological evidence from a tissue sample obtained by biopsy, which is then examined under a microscope.
12 June 2017
Doctors are limited by their inability to process vast amounts of data the way a computer can, and as technology improves, artificial intelligence has begun to catch up with doctors’...
2 May 2017
The current generation is surrounded by large amounts of information and knowledge on almost any topic of interest, including a variety of online symptom-checkers encouraging self-diagnosis.
21 April 2017
Over the last few decades, cardiac implantable electronic devices have contributed to the survival and quality of life of patients with cardiovascular related diseases.
20 April 2017
Dr Philip Mack recently presented data in the Proceedings of the American Society of Clinical Oncology Annual meeting suggesting liquid biopsy detected cancer mutations in 85% of all advanced tumours...
30 March 2017
Bladder cancer is among the most expensive cancers to treat. Reasons for this include a high recurrence rate and the need for ongoing invasive surveillance. Patients with a known history...